Skip to content
Toggle main navigation
About
About TEPHINET
About TEPHIConnect
Terms of Use and Privacy
How to Join
Why Join?
News
Events
Groups
Journals
BMC Medicine
BMC Medical Research Methodology
Clinical Epidemiology and Global Health
Emerging Microbes & Infections
Frontiers in Epidemiology
Global Health Journal
International Journal of Epidemiology
Online Library Journal
PLoS One
Science Direct Journal (Global Health)
Science Direct Journal (Clinical Epidemiology and Global Health)
More
Open dropdown to see remaining menu items
Log in
Request to join
Erratum: Vol. 70, No. 12
Published on April 29, 2021
Erratum: Vol. 70, No. 12
Continue reading on website
Other news
EARLY RELEASE: Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
April 28, 2021
In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
EARLY RELEASE: Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
April 30, 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.